[Analysis of Transfusion Therapy Effectiveness in Patients with Myelodysplastic Syndrome].
Lists
Only you see this
Abstract
In the process of component transfusion for MDS patients, compared with the transfusion of red blood cells, the inefficiencies of platelet transfusion significantly increased, mainly due to the disorder of blood coagulation and the generation of platelet antibodies in MDS patients with ineffective platelet transfusion. Compared with the normal control group, human P selectin and human anti-thrombin 3 antibody significantly increase and human tissue factor pathway inhibitor significantly decreases in MDS patients with ineffective platelet transfusion. Human P selectin, human anti-thrombin 3 antibody and human tissue factor pathway inhibitor in molecular markers and fibrinolytic markers can be used as indicators of platelet transfusion time and efficiency in patients with MDS.
BibTeX
@inproceedings{yin2020analysis,
author = {Zhenhua Yin and Zhi-Rui Pang and Xian-Chun Fang and Xiaojun Kong and Yan Cheng and Junji He and Juan Xu and Shuang Chen and Feng Zhu and Chen Yang and Qiu-Xiang Tan and Lin Gui and Jinning Shi and Hongmei Zhang},
title = {{[Analysis of Transfusion Therapy Effectiveness in Patients with Myelodysplastic Syndrome].}},
booktitle = {PubMed},
year = {2020},
doi = {10.19746/j.cnki.issn.1009-2137.2020.05.036},
}Loading related content...